Bilirakis, Matsui, Klobuchar, & Wicker, Announce New FDA Rare Disease Innovation Hub
July 29, 2024
July 29, 2024
WASHINGTON, July 29 -- Rep. Gus M. Bilirakis, R-Florida, issued the following news release:
Senators Amy Klobuchar (D-MN) and Roger Wicker (R-MS) and U.S. Representatives Gus Bilirakis (R-FL) and Doris Matsui (D-CA), co-chairs of the bipartisan Rare Disease Congressional Caucus (RDCC), applaud the Food and Drug Administration (FDA) announcement of the creation of a Rare Disease Innovation Hub. The Rare Disease Innovation Hub will serve as a single point of connection and engagement . . .
Senators Amy Klobuchar (D-MN) and Roger Wicker (R-MS) and U.S. Representatives Gus Bilirakis (R-FL) and Doris Matsui (D-CA), co-chairs of the bipartisan Rare Disease Congressional Caucus (RDCC), applaud the Food and Drug Administration (FDA) announcement of the creation of a Rare Disease Innovation Hub. The Rare Disease Innovation Hub will serve as a single point of connection and engagement . . .